LEUKEMIA-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=575410, encodeId=27845e541068, content=一审审了一个月。给了60天修回今天回去了不知道多久接收。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=281, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epO9VOvOZJjg2P7fag0bnHJrkLRHJMdPBTCLH2nCTicNh2v7xatCBDVoXw1wze6Rk109HE4OnFvDUA/132, createdBy=8f782185877, createdName=蒋咚咚咚鹏, createdTime=Tue Aug 27 00:00:00 CST 2019, time=2019-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583364, encodeId=07875833649a, content=请问有leukemia投稿以后没有收到确认邮件的小伙伴吗，刚刚投的，状态显示underconsideration，但是没有收到系统邮件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=256, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0f025265573, createdName=14810008m75暂无昵称, createdTime=Wed Jan 15 00:00:00 CST 2020, time=2020-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833286, encodeId=fcfb83328600, content=审稿速度:1.0 经验分享：我刚投出去一篇，已经好几天了，还是处于under consideration的状态，是什么原因？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=189, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7555414117, createdName=ms61234328952836, createdTime=Mon Aug 22 11:46:40 CST 2016, time=2016-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=519021, encodeId=511d51902151, content=收到投稿成功email了吗？wpwan 2016-01-31 发表:: 刚投出去一篇，已经5天了，还是处于under consideration的状态，是不是投稿少了哪个步骤？有经验的专家给指导一下，谢谢！, beContent=wpwan 2016-01-31 发表:: 刚投出去一篇，已经5天了，还是处于under consideration的状态，是不是投稿少了哪个步骤？有经验的专家给指导一下，谢谢！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=441, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/25/850a0019c76e773515fbe27fc2998137.jpg, createdBy=d20b94956, createdName=fulin2222, createdTime=Thu Feb 04 10:02:00 CST 2016, time=2016-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518923, encodeId=3efc518923ef, content=刚投出去一篇，已经5天了，还是处于under consideration的状态，是不是投稿少了哪个步骤？有经验的专家给指导一下，谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=303, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e17997960, createdName=wpwan, createdTime=Sun Jan 31 12:37:00 CST 2016, time=2016-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=508846, encodeId=95bb5088468b, content=9月底投稿，10月15号回信大修，修了2个多月，12月返回小修搞了几个语法错误，1月26号接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=373, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Dec 31 08:12:00 CST 2014, time=2014-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=502613, encodeId=d9db502613fd, content=楼上写的不会是这篇吧The miRNA-17B92 cluster mediates chemoresistance and enhances tumor growth in mantle cell lymphoma via PI3K/AKT pathway activation, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=362, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Mon Apr 28 10:50:00 CST 2014, time=2014-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=501162, encodeId=7ee450116233, content=请问leukemia审稿需要收费吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=395, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Feb 18 10:50:00 CST 2014, time=2014-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=489119, encodeId=2c524891191c, content=review1 个月，大修4个月，1w 接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=478, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Jun 26 06:09:00 CST 2012, time=2012-06-26, status=1, ipAttribution=)]

2019-08-27 蒋咚咚咚鹏

一审审了一个月。给了60天修回今天回去了不知道多久接收。。。

281 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=575410, encodeId=27845e541068, content=一审审了一个月。给了60天修回今天回去了不知道多久接收。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=281, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epO9VOvOZJjg2P7fag0bnHJrkLRHJMdPBTCLH2nCTicNh2v7xatCBDVoXw1wze6Rk109HE4OnFvDUA/132, createdBy=8f782185877, createdName=蒋咚咚咚鹏, createdTime=Tue Aug 27 00:00:00 CST 2019, time=2019-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583364, encodeId=07875833649a, content=请问有leukemia投稿以后没有收到确认邮件的小伙伴吗，刚刚投的，状态显示underconsideration，但是没有收到系统邮件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=256, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0f025265573, createdName=14810008m75暂无昵称, createdTime=Wed Jan 15 00:00:00 CST 2020, time=2020-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833286, encodeId=fcfb83328600, content=审稿速度:1.0 经验分享：我刚投出去一篇，已经好几天了，还是处于under consideration的状态，是什么原因？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=189, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7555414117, createdName=ms61234328952836, createdTime=Mon Aug 22 11:46:40 CST 2016, time=2016-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=519021, encodeId=511d51902151, content=收到投稿成功email了吗？wpwan 2016-01-31 发表:: 刚投出去一篇，已经5天了，还是处于under consideration的状态，是不是投稿少了哪个步骤？有经验的专家给指导一下，谢谢！, beContent=wpwan 2016-01-31 发表:: 刚投出去一篇，已经5天了，还是处于under consideration的状态，是不是投稿少了哪个步骤？有经验的专家给指导一下，谢谢！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=441, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/25/850a0019c76e773515fbe27fc2998137.jpg, createdBy=d20b94956, createdName=fulin2222, createdTime=Thu Feb 04 10:02:00 CST 2016, time=2016-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518923, encodeId=3efc518923ef, content=刚投出去一篇，已经5天了，还是处于under consideration的状态，是不是投稿少了哪个步骤？有经验的专家给指导一下，谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=303, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e17997960, createdName=wpwan, createdTime=Sun Jan 31 12:37:00 CST 2016, time=2016-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=508846, encodeId=95bb5088468b, content=9月底投稿，10月15号回信大修，修了2个多月，12月返回小修搞了几个语法错误，1月26号接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=373, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Dec 31 08:12:00 CST 2014, time=2014-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=502613, encodeId=d9db502613fd, content=楼上写的不会是这篇吧The miRNA-17B92 cluster mediates chemoresistance and enhances tumor growth in mantle cell lymphoma via PI3K/AKT pathway activation, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=362, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Mon Apr 28 10:50:00 CST 2014, time=2014-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=501162, encodeId=7ee450116233, content=请问leukemia审稿需要收费吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=395, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Feb 18 10:50:00 CST 2014, time=2014-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=489119, encodeId=2c524891191c, content=review1 个月，大修4个月，1w 接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=478, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Jun 26 06:09:00 CST 2012, time=2012-06-26, status=1, ipAttribution=)]

2020-01-15 14810008m75暂无昵称

请问有leukemia投稿以后没有收到确认邮件的小伙伴吗，刚刚投的，状态显示underconsideration，但是没有收到系统邮件

256 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=575410, encodeId=27845e541068, content=一审审了一个月。给了60天修回今天回去了不知道多久接收。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=281, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epO9VOvOZJjg2P7fag0bnHJrkLRHJMdPBTCLH2nCTicNh2v7xatCBDVoXw1wze6Rk109HE4OnFvDUA/132, createdBy=8f782185877, createdName=蒋咚咚咚鹏, createdTime=Tue Aug 27 00:00:00 CST 2019, time=2019-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583364, encodeId=07875833649a, content=请问有leukemia投稿以后没有收到确认邮件的小伙伴吗，刚刚投的，状态显示underconsideration，但是没有收到系统邮件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=256, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0f025265573, createdName=14810008m75暂无昵称, createdTime=Wed Jan 15 00:00:00 CST 2020, time=2020-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833286, encodeId=fcfb83328600, content=审稿速度:1.0 经验分享：我刚投出去一篇，已经好几天了，还是处于under consideration的状态，是什么原因？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=189, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7555414117, createdName=ms61234328952836, createdTime=Mon Aug 22 11:46:40 CST 2016, time=2016-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=519021, encodeId=511d51902151, content=收到投稿成功email了吗？wpwan 2016-01-31 发表:: 刚投出去一篇，已经5天了，还是处于under consideration的状态，是不是投稿少了哪个步骤？有经验的专家给指导一下，谢谢！, beContent=wpwan 2016-01-31 发表:: 刚投出去一篇，已经5天了，还是处于under consideration的状态，是不是投稿少了哪个步骤？有经验的专家给指导一下，谢谢！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=441, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/25/850a0019c76e773515fbe27fc2998137.jpg, createdBy=d20b94956, createdName=fulin2222, createdTime=Thu Feb 04 10:02:00 CST 2016, time=2016-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518923, encodeId=3efc518923ef, content=刚投出去一篇，已经5天了，还是处于under consideration的状态，是不是投稿少了哪个步骤？有经验的专家给指导一下，谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=303, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e17997960, createdName=wpwan, createdTime=Sun Jan 31 12:37:00 CST 2016, time=2016-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=508846, encodeId=95bb5088468b, content=9月底投稿，10月15号回信大修，修了2个多月，12月返回小修搞了几个语法错误，1月26号接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=373, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Dec 31 08:12:00 CST 2014, time=2014-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=502613, encodeId=d9db502613fd, content=楼上写的不会是这篇吧The miRNA-17B92 cluster mediates chemoresistance and enhances tumor growth in mantle cell lymphoma via PI3K/AKT pathway activation, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=362, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Mon Apr 28 10:50:00 CST 2014, time=2014-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=501162, encodeId=7ee450116233, content=请问leukemia审稿需要收费吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=395, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Feb 18 10:50:00 CST 2014, time=2014-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=489119, encodeId=2c524891191c, content=review1 个月，大修4个月，1w 接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=478, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Jun 26 06:09:00 CST 2012, time=2012-06-26, status=1, ipAttribution=)]

2016-08-22 ms61234328952836

审稿速度:1.0
经验分享：我刚投出去一篇，已经好几天了，还是处于under consideration的状态，是什么原因？

189 0

[GetPortalCommentsPageByObjectIdResponse(id=575410, encodeId=27845e541068, content=一审审了一个月。给了60天修回今天回去了不知道多久接收。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=281, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epO9VOvOZJjg2P7fag0bnHJrkLRHJMdPBTCLH2nCTicNh2v7xatCBDVoXw1wze6Rk109HE4OnFvDUA/132, createdBy=8f782185877, createdName=蒋咚咚咚鹏, createdTime=Tue Aug 27 00:00:00 CST 2019, time=2019-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583364, encodeId=07875833649a, content=请问有leukemia投稿以后没有收到确认邮件的小伙伴吗，刚刚投的，状态显示underconsideration，但是没有收到系统邮件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=256, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0f025265573, createdName=14810008m75暂无昵称, createdTime=Wed Jan 15 00:00:00 CST 2020, time=2020-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833286, encodeId=fcfb83328600, content=审稿速度:1.0 经验分享：我刚投出去一篇，已经好几天了，还是处于under consideration的状态，是什么原因？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=189, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7555414117, createdName=ms61234328952836, createdTime=Mon Aug 22 11:46:40 CST 2016, time=2016-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=519021, encodeId=511d51902151, content=收到投稿成功email了吗？wpwan 2016-01-31 发表:: 刚投出去一篇，已经5天了，还是处于under consideration的状态，是不是投稿少了哪个步骤？有经验的专家给指导一下，谢谢！, beContent=wpwan 2016-01-31 发表:: 刚投出去一篇，已经5天了，还是处于under consideration的状态，是不是投稿少了哪个步骤？有经验的专家给指导一下，谢谢！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=441, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/25/850a0019c76e773515fbe27fc2998137.jpg, createdBy=d20b94956, createdName=fulin2222, createdTime=Thu Feb 04 10:02:00 CST 2016, time=2016-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518923, encodeId=3efc518923ef, content=刚投出去一篇，已经5天了，还是处于under consideration的状态，是不是投稿少了哪个步骤？有经验的专家给指导一下，谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=303, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e17997960, createdName=wpwan, createdTime=Sun Jan 31 12:37:00 CST 2016, time=2016-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=508846, encodeId=95bb5088468b, content=9月底投稿，10月15号回信大修，修了2个多月，12月返回小修搞了几个语法错误，1月26号接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=373, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Dec 31 08:12:00 CST 2014, time=2014-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=502613, encodeId=d9db502613fd, content=楼上写的不会是这篇吧The miRNA-17B92 cluster mediates chemoresistance and enhances tumor growth in mantle cell lymphoma via PI3K/AKT pathway activation, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=362, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Mon Apr 28 10:50:00 CST 2014, time=2014-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=501162, encodeId=7ee450116233, content=请问leukemia审稿需要收费吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=395, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Feb 18 10:50:00 CST 2014, time=2014-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=489119, encodeId=2c524891191c, content=review1 个月，大修4个月，1w 接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=478, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Jun 26 06:09:00 CST 2012, time=2012-06-26, status=1, ipAttribution=)]

2016-02-04 fulin2222

收到投稿成功email了吗？wpwan 2016-01-31 发表::
刚投出去一篇，已经5天了，还是处于under consideration的状态，是不是投稿少了哪个步骤？有经验的专家给指导一下，谢谢！

wpwan 2016-01-31 发表:: 刚投出去一篇，已经5天了，还是处于under consideration的状态，是不是投稿少了哪个步骤？有经验的专家给指导一下，谢谢！

441 0

[GetPortalCommentsPageByObjectIdResponse(id=575410, encodeId=27845e541068, content=一审审了一个月。给了60天修回今天回去了不知道多久接收。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=281, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epO9VOvOZJjg2P7fag0bnHJrkLRHJMdPBTCLH2nCTicNh2v7xatCBDVoXw1wze6Rk109HE4OnFvDUA/132, createdBy=8f782185877, createdName=蒋咚咚咚鹏, createdTime=Tue Aug 27 00:00:00 CST 2019, time=2019-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583364, encodeId=07875833649a, content=请问有leukemia投稿以后没有收到确认邮件的小伙伴吗，刚刚投的，状态显示underconsideration，但是没有收到系统邮件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=256, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0f025265573, createdName=14810008m75暂无昵称, createdTime=Wed Jan 15 00:00:00 CST 2020, time=2020-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833286, encodeId=fcfb83328600, content=审稿速度:1.0 经验分享：我刚投出去一篇，已经好几天了，还是处于under consideration的状态，是什么原因？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=189, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7555414117, createdName=ms61234328952836, createdTime=Mon Aug 22 11:46:40 CST 2016, time=2016-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=519021, encodeId=511d51902151, content=收到投稿成功email了吗？wpwan 2016-01-31 发表:: 刚投出去一篇，已经5天了，还是处于under consideration的状态，是不是投稿少了哪个步骤？有经验的专家给指导一下，谢谢！, beContent=wpwan 2016-01-31 发表:: 刚投出去一篇，已经5天了，还是处于under consideration的状态，是不是投稿少了哪个步骤？有经验的专家给指导一下，谢谢！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=441, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/25/850a0019c76e773515fbe27fc2998137.jpg, createdBy=d20b94956, createdName=fulin2222, createdTime=Thu Feb 04 10:02:00 CST 2016, time=2016-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518923, encodeId=3efc518923ef, content=刚投出去一篇，已经5天了，还是处于under consideration的状态，是不是投稿少了哪个步骤？有经验的专家给指导一下，谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=303, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e17997960, createdName=wpwan, createdTime=Sun Jan 31 12:37:00 CST 2016, time=2016-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=508846, encodeId=95bb5088468b, content=9月底投稿，10月15号回信大修，修了2个多月，12月返回小修搞了几个语法错误，1月26号接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=373, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Dec 31 08:12:00 CST 2014, time=2014-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=502613, encodeId=d9db502613fd, content=楼上写的不会是这篇吧The miRNA-17B92 cluster mediates chemoresistance and enhances tumor growth in mantle cell lymphoma via PI3K/AKT pathway activation, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=362, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Mon Apr 28 10:50:00 CST 2014, time=2014-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=501162, encodeId=7ee450116233, content=请问leukemia审稿需要收费吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=395, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Feb 18 10:50:00 CST 2014, time=2014-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=489119, encodeId=2c524891191c, content=review1 个月，大修4个月，1w 接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=478, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Jun 26 06:09:00 CST 2012, time=2012-06-26, status=1, ipAttribution=)]

2016-01-31 wpwan

刚投出去一篇，已经5天了，还是处于under consideration的状态，是不是投稿少了哪个步骤？有经验的专家给指导一下，谢谢！

303 0

[GetPortalCommentsPageByObjectIdResponse(id=575410, encodeId=27845e541068, content=一审审了一个月。给了60天修回今天回去了不知道多久接收。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=281, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epO9VOvOZJjg2P7fag0bnHJrkLRHJMdPBTCLH2nCTicNh2v7xatCBDVoXw1wze6Rk109HE4OnFvDUA/132, createdBy=8f782185877, createdName=蒋咚咚咚鹏, createdTime=Tue Aug 27 00:00:00 CST 2019, time=2019-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583364, encodeId=07875833649a, content=请问有leukemia投稿以后没有收到确认邮件的小伙伴吗，刚刚投的，状态显示underconsideration，但是没有收到系统邮件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=256, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0f025265573, createdName=14810008m75暂无昵称, createdTime=Wed Jan 15 00:00:00 CST 2020, time=2020-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833286, encodeId=fcfb83328600, content=审稿速度:1.0 经验分享：我刚投出去一篇，已经好几天了，还是处于under consideration的状态，是什么原因？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=189, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7555414117, createdName=ms61234328952836, createdTime=Mon Aug 22 11:46:40 CST 2016, time=2016-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=519021, encodeId=511d51902151, content=收到投稿成功email了吗？wpwan 2016-01-31 发表:: 刚投出去一篇，已经5天了，还是处于under consideration的状态，是不是投稿少了哪个步骤？有经验的专家给指导一下，谢谢！, beContent=wpwan 2016-01-31 发表:: 刚投出去一篇，已经5天了，还是处于under consideration的状态，是不是投稿少了哪个步骤？有经验的专家给指导一下，谢谢！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=441, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/25/850a0019c76e773515fbe27fc2998137.jpg, createdBy=d20b94956, createdName=fulin2222, createdTime=Thu Feb 04 10:02:00 CST 2016, time=2016-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518923, encodeId=3efc518923ef, content=刚投出去一篇，已经5天了，还是处于under consideration的状态，是不是投稿少了哪个步骤？有经验的专家给指导一下，谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=303, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e17997960, createdName=wpwan, createdTime=Sun Jan 31 12:37:00 CST 2016, time=2016-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=508846, encodeId=95bb5088468b, content=9月底投稿，10月15号回信大修，修了2个多月，12月返回小修搞了几个语法错误，1月26号接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=373, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Dec 31 08:12:00 CST 2014, time=2014-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=502613, encodeId=d9db502613fd, content=楼上写的不会是这篇吧The miRNA-17B92 cluster mediates chemoresistance and enhances tumor growth in mantle cell lymphoma via PI3K/AKT pathway activation, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=362, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Mon Apr 28 10:50:00 CST 2014, time=2014-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=501162, encodeId=7ee450116233, content=请问leukemia审稿需要收费吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=395, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Feb 18 10:50:00 CST 2014, time=2014-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=489119, encodeId=2c524891191c, content=review1 个月，大修4个月，1w 接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=478, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Jun 26 06:09:00 CST 2012, time=2012-06-26, status=1, ipAttribution=)]

2014-12-31 匿名用户

9月底投稿，10月15号回信大修，修了2个多月，12月返回小修搞了几个语法错误，1月26号接收

373 0

[GetPortalCommentsPageByObjectIdResponse(id=575410, encodeId=27845e541068, content=一审审了一个月。给了60天修回今天回去了不知道多久接收。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=281, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epO9VOvOZJjg2P7fag0bnHJrkLRHJMdPBTCLH2nCTicNh2v7xatCBDVoXw1wze6Rk109HE4OnFvDUA/132, createdBy=8f782185877, createdName=蒋咚咚咚鹏, createdTime=Tue Aug 27 00:00:00 CST 2019, time=2019-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583364, encodeId=07875833649a, content=请问有leukemia投稿以后没有收到确认邮件的小伙伴吗，刚刚投的，状态显示underconsideration，但是没有收到系统邮件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=256, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0f025265573, createdName=14810008m75暂无昵称, createdTime=Wed Jan 15 00:00:00 CST 2020, time=2020-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833286, encodeId=fcfb83328600, content=审稿速度:1.0 经验分享：我刚投出去一篇，已经好几天了，还是处于under consideration的状态，是什么原因？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=189, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7555414117, createdName=ms61234328952836, createdTime=Mon Aug 22 11:46:40 CST 2016, time=2016-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=519021, encodeId=511d51902151, content=收到投稿成功email了吗？wpwan 2016-01-31 发表:: 刚投出去一篇，已经5天了，还是处于under consideration的状态，是不是投稿少了哪个步骤？有经验的专家给指导一下，谢谢！, beContent=wpwan 2016-01-31 发表:: 刚投出去一篇，已经5天了，还是处于under consideration的状态，是不是投稿少了哪个步骤？有经验的专家给指导一下，谢谢！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=441, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/25/850a0019c76e773515fbe27fc2998137.jpg, createdBy=d20b94956, createdName=fulin2222, createdTime=Thu Feb 04 10:02:00 CST 2016, time=2016-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518923, encodeId=3efc518923ef, content=刚投出去一篇，已经5天了，还是处于under consideration的状态，是不是投稿少了哪个步骤？有经验的专家给指导一下，谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=303, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e17997960, createdName=wpwan, createdTime=Sun Jan 31 12:37:00 CST 2016, time=2016-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=508846, encodeId=95bb5088468b, content=9月底投稿，10月15号回信大修，修了2个多月，12月返回小修搞了几个语法错误，1月26号接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=373, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Dec 31 08:12:00 CST 2014, time=2014-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=502613, encodeId=d9db502613fd, content=楼上写的不会是这篇吧The miRNA-17B92 cluster mediates chemoresistance and enhances tumor growth in mantle cell lymphoma via PI3K/AKT pathway activation, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=362, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Mon Apr 28 10:50:00 CST 2014, time=2014-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=501162, encodeId=7ee450116233, content=请问leukemia审稿需要收费吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=395, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Feb 18 10:50:00 CST 2014, time=2014-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=489119, encodeId=2c524891191c, content=review1 个月，大修4个月，1w 接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=478, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Jun 26 06:09:00 CST 2012, time=2012-06-26, status=1, ipAttribution=)]

2014-04-28 匿名用户

楼上写的不会是这篇吧The miRNA-17B92 cluster mediates chemoresistance
and enhances tumor growth in mantle cell lymphoma via
PI3K/AKT pathway activation

362 0

[GetPortalCommentsPageByObjectIdResponse(id=575410, encodeId=27845e541068, content=一审审了一个月。给了60天修回今天回去了不知道多久接收。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=281, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epO9VOvOZJjg2P7fag0bnHJrkLRHJMdPBTCLH2nCTicNh2v7xatCBDVoXw1wze6Rk109HE4OnFvDUA/132, createdBy=8f782185877, createdName=蒋咚咚咚鹏, createdTime=Tue Aug 27 00:00:00 CST 2019, time=2019-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583364, encodeId=07875833649a, content=请问有leukemia投稿以后没有收到确认邮件的小伙伴吗，刚刚投的，状态显示underconsideration，但是没有收到系统邮件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=256, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0f025265573, createdName=14810008m75暂无昵称, createdTime=Wed Jan 15 00:00:00 CST 2020, time=2020-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833286, encodeId=fcfb83328600, content=审稿速度:1.0 经验分享：我刚投出去一篇，已经好几天了，还是处于under consideration的状态，是什么原因？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=189, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7555414117, createdName=ms61234328952836, createdTime=Mon Aug 22 11:46:40 CST 2016, time=2016-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=519021, encodeId=511d51902151, content=收到投稿成功email了吗？wpwan 2016-01-31 发表:: 刚投出去一篇，已经5天了，还是处于under consideration的状态，是不是投稿少了哪个步骤？有经验的专家给指导一下，谢谢！, beContent=wpwan 2016-01-31 发表:: 刚投出去一篇，已经5天了，还是处于under consideration的状态，是不是投稿少了哪个步骤？有经验的专家给指导一下，谢谢！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=441, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/25/850a0019c76e773515fbe27fc2998137.jpg, createdBy=d20b94956, createdName=fulin2222, createdTime=Thu Feb 04 10:02:00 CST 2016, time=2016-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518923, encodeId=3efc518923ef, content=刚投出去一篇，已经5天了，还是处于under consideration的状态，是不是投稿少了哪个步骤？有经验的专家给指导一下，谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=303, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e17997960, createdName=wpwan, createdTime=Sun Jan 31 12:37:00 CST 2016, time=2016-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=508846, encodeId=95bb5088468b, content=9月底投稿，10月15号回信大修，修了2个多月，12月返回小修搞了几个语法错误，1月26号接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=373, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Dec 31 08:12:00 CST 2014, time=2014-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=502613, encodeId=d9db502613fd, content=楼上写的不会是这篇吧The miRNA-17B92 cluster mediates chemoresistance and enhances tumor growth in mantle cell lymphoma via PI3K/AKT pathway activation, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=362, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Mon Apr 28 10:50:00 CST 2014, time=2014-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=501162, encodeId=7ee450116233, content=请问leukemia审稿需要收费吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=395, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Feb 18 10:50:00 CST 2014, time=2014-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=489119, encodeId=2c524891191c, content=review1 个月，大修4个月，1w 接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=478, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Jun 26 06:09:00 CST 2012, time=2012-06-26, status=1, ipAttribution=)]

2014-02-18 匿名用户

请问leukemia审稿需要收费吗

395 0

[GetPortalCommentsPageByObjectIdResponse(id=575410, encodeId=27845e541068, content=一审审了一个月。给了60天修回今天回去了不知道多久接收。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=281, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epO9VOvOZJjg2P7fag0bnHJrkLRHJMdPBTCLH2nCTicNh2v7xatCBDVoXw1wze6Rk109HE4OnFvDUA/132, createdBy=8f782185877, createdName=蒋咚咚咚鹏, createdTime=Tue Aug 27 00:00:00 CST 2019, time=2019-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583364, encodeId=07875833649a, content=请问有leukemia投稿以后没有收到确认邮件的小伙伴吗，刚刚投的，状态显示underconsideration，但是没有收到系统邮件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=256, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0f025265573, createdName=14810008m75暂无昵称, createdTime=Wed Jan 15 00:00:00 CST 2020, time=2020-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833286, encodeId=fcfb83328600, content=审稿速度:1.0 经验分享：我刚投出去一篇，已经好几天了，还是处于under consideration的状态，是什么原因？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=189, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7555414117, createdName=ms61234328952836, createdTime=Mon Aug 22 11:46:40 CST 2016, time=2016-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=519021, encodeId=511d51902151, content=收到投稿成功email了吗？wpwan 2016-01-31 发表:: 刚投出去一篇，已经5天了，还是处于under consideration的状态，是不是投稿少了哪个步骤？有经验的专家给指导一下，谢谢！, beContent=wpwan 2016-01-31 发表:: 刚投出去一篇，已经5天了，还是处于under consideration的状态，是不是投稿少了哪个步骤？有经验的专家给指导一下，谢谢！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=441, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/25/850a0019c76e773515fbe27fc2998137.jpg, createdBy=d20b94956, createdName=fulin2222, createdTime=Thu Feb 04 10:02:00 CST 2016, time=2016-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518923, encodeId=3efc518923ef, content=刚投出去一篇，已经5天了，还是处于under consideration的状态，是不是投稿少了哪个步骤？有经验的专家给指导一下，谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=303, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e17997960, createdName=wpwan, createdTime=Sun Jan 31 12:37:00 CST 2016, time=2016-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=508846, encodeId=95bb5088468b, content=9月底投稿，10月15号回信大修，修了2个多月，12月返回小修搞了几个语法错误，1月26号接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=373, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Dec 31 08:12:00 CST 2014, time=2014-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=502613, encodeId=d9db502613fd, content=楼上写的不会是这篇吧The miRNA-17B92 cluster mediates chemoresistance and enhances tumor growth in mantle cell lymphoma via PI3K/AKT pathway activation, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=362, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Mon Apr 28 10:50:00 CST 2014, time=2014-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=501162, encodeId=7ee450116233, content=请问leukemia审稿需要收费吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=395, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Feb 18 10:50:00 CST 2014, time=2014-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=489119, encodeId=2c524891191c, content=review1 个月，大修4个月，1w 接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=478, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Jun 26 06:09:00 CST 2012, time=2012-06-26, status=1, ipAttribution=)]

2012-06-26 匿名用户

review1 个月，大修4个月，1w 接受。

478 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务